Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
This study used sample size analysis to determine the adequately sized intervention group and control group, well-defined statistical methodology, and a well-documented intervention that can be easily replicated. The intervention has been developed by Dr. Phillips Center for the Performing Arts leadership with assistance from AMS Planning \& Research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary, unpaid caregiver of person with dementia OR
- • Person with Dementia.
- • Live independently in the community.
- • Care recipient has a Functional Assessment Staging Test (FAST) Score of 4-6b.
- • Caregiver does not display symptoms of emotional, cognitive, or mental impairment.
- • Caregiver must be able to produce adequate saliva sample.
- • Caregiver/care recipient can travel to program.
- • Caregiver/care recipient agree to participate in all aspects of study intervention and assessments.
- • Caregiver is 18 years of age or older.
- • Care recipient is 65 years of age or older
- • Access to home phone or mobile phone
- Exclusion Criteria:
- • Unable to understand either spoken and/or written English.
- • Caregiver is a paid employee of care recipient's legally appointed representative
About Adventhealth
AdventHealth is a comprehensive, faith-based healthcare organization dedicated to providing holistic care and advancing medical research through innovative clinical trials. With a commitment to improving patient outcomes and enhancing the quality of life, AdventHealth integrates cutting-edge technology and compassionate care across its extensive network of hospitals and outpatient facilities. The organization emphasizes a patient-centered approach, fostering collaboration among multidisciplinary teams to explore new treatment options and therapies. By participating in clinical research, AdventHealth aims to contribute to the advancement of medical knowledge and deliver transformative healthcare solutions to communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Kim McManus, PhD
Principal Investigator
AdventHealth
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials